THERAPEUTICAL USE OF ANTI-MYELIN ASSOCIATED GLYCOPROTEIN (MAG) ANTIBODIES

摘要

A method of promoting oligodendrocyte survival in a human suffering or at risk of developing stroke or another neurological disease which comprises administering to said human a therapeutically effective amount of an anti-MAG antibody or a functional fragment thereof.